Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-10-05 Purchase | 2023-10-06 07:38 am | Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer | 22,727 | $22 | $499,994 | 189,380 (Direct) | View |
| 2022-10-25 Purchase | 2022-10-26 6:21 pm | Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer | 142,857 | $10.5 | $1,499,999 | 166,653 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-02 Option Award | 2024-01-04 8:07 pm | N/A 2034-01-02 | Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer | 96,250 | $0 | 96,250 (Direct) | View |
| 2023-11-02 Option Award | 2023-11-06 8:34 pm | N/A 2033-11-02 | Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer | 78,750 | $0 | 78,750 (Direct) | View |
| 2022-10-03 Tax Withholding | 2022-10-05 5:36 pm | N/A N/A | Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer | 11,042 | $7.5 | 358,634 (Direct) | View |
| 2022-10-03 Option Award | 2022-10-05 5:36 pm | N/A 2032-10-04 | Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer | 300,000 | $0 | 358,634 (Direct) | View |
| 2022-10-03 Exercise | 2022-10-05 5:36 pm | N/A N/A | Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer | 13,000 | $6.37 | 358,634 (Direct) | View |
| 2022-10-03 Other | 2022-10-05 5:36 pm | N/A 2032-01-07 | Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer | 34,838 | $0 | 358,634 (Direct) | View |
| 2022-10-03 Exercise | 2022-10-05 5:36 pm | N/A 2032-01-07 | Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer | 13,000 | $0 | 358,634 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:28 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Chief Financial Officer | 63,500 | $0 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:28 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Chief Financial Officer | 6,177 | $148.5 | 0 (Direct) | View |
Ownership | 2022-09-28 8:51 pm | N/A N/A | Biohaven Ltd. | BHVN | Buten Matthew Treasurer | 0 | $0 | 0 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-07 9:19 pm | N/A 2032-01-07 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Chief Financial Officer | 26,000 | $0 | 26,000 (Direct) | View |
| 2021-12-31 Tax Withholding | 2022-01-04 9:30 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Chief Financial Officer | 6,323 | $137.81 | 43,677 (Direct) | View |
| 2021-12-31 Exercise | 2022-01-04 9:30 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Chief Financial Officer | 12,500 | $0 | 43,677 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-14 8:52 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Officer | 50,000 | $0 | 50,000 (Direct) | View |